The scientists tested emerging variants B.1.1351 (Beta), B.1.1.7 (Alpha) and P.1 (Gamma) and found the level of inhibition to viral variants was significantly lower, ranging from 67 per cent to 92 per cent.
This finding confirms that there are large differences in the number of secondary cases generated by infected people, with the majority of infections generating no further infections and a minority of the infections generating a large number of infections.
As per studies, the Spike-protein antibodies (Immunoglobulin G or IgG) may last in human body for at least 6-months against the Covid-19 virus. But doctors say test need to be taken after 14-days post recovering from Covid-19 or after vaccination
Cuttack: A Serological survey which was extensively conducted in the municipal corporation area in the last few days has revealed that 46.39 per cent residents of the Silver City have developed COVID-19 antibodies in them. Briefing the press about the latest development, Commissioner of Cuttack Municipal Corporation, Ananya Das said, “A total of 2274 blood […]